There’s a pharmacy in the White House — or, at least, there’s a sign that says “Pharmacy,” though the people in charge insist it isn’t one. Whatever they call it, the office has had enough internal complaints to warrant a government watchdog investigation. Much of the report, which was based on interviews with dozens of officials who worked in the office between 2009 and 2018, focused on the handling of prescription medicines. Gregory Demske, Complex Litigation & Dispute Resolution and Healthcare partner who previously served as chief counsel to the inspector general at the Department of Health and Human Services, called that delay “troubling” and “highly unusual.” It should only take a couple months to work out any technical corrections and agree to recommendations for policy changes, he said to STAT, and the delay, “unfortunately, makes the report less timely.”